Pharmacy World and Science

, Volume 15, Issue 5, pp 230–232 | Cite as

The antiproteinuric effect of ACE inhibition in renal disease

  • J. E. Heeg
Doctoral Theses


Proteinuria due to non-steroid-responsive renal disease may be harmful. Firstly, because it may cause a nephrotic syndrome, and, secondly, because it is, like hypertension, associated with an increased risk of progressive renal damage and loss of renal function over the years. Until recently, only non-steroidal antiinflammatory drugs (NSAIDs) were available to reduce proteinuria in such patients. Due to their potential side-effects, however, NSAIDs have never been widely used as antiproteinuric agents. In 1985 some studies were published showing that inhibition of angiotensin-converting enzyme (ACE) not only reduced the elevated blood pressure in rats with chronic renal failure (experimentally induced by renal ablation or by induced diabetic nephropathy), but also prevented the development of glomerular damage with proteinuria and loss of renal function in these animals. This beneficial effect of ACE inhibition was attributed to the prevention of glomerular hypertension. At the same time it was reported that ACE inhibition could reduce proteinuria in patients with advanced diabetic nephropathy. ACE inhibitors might thus be an attractive alternative for NSAIDs as antiproteinuric treatment, possibly being renoprotective, and being generally well-tolerated.


Angiotensin II Angiotensin-converting enzyme inhibitors Blood pressure Glomerular filtration rate Hemodynamics, renal Lisinopril Nephrotic syndrome Proteinuria 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Periodicals Service Company 1993

Authors and Affiliations

  • J. E. Heeg
    • 1
    • 2
  1. 1.Sophia Ziekenhuis ZwolleGK ZwolleThe Netherlands
  2. 2.University of GroningenGroningen

Personalised recommendations